Rosiglitazone 's effects on fasting ( -0.36 mmol/l ; P = 0.0004 ) and 2-h post-load glucose ( -1.21 mmol/l ; P = 0.0008 ) were not affected by adjustment for fat distribution or changes in adiponectin or free fatty acids .